Literature DB >> 23632358

Resolution of severe Clostridium difficile infection following sequential fecal microbiota transplantation.

Alexa R Weingarden, Matthew J Hamilton, Michael J Sadowsky, Alexander Khoruts.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 23632358      PMCID: PMC3735621          DOI: 10.1097/MCG.0b013e31829004ae

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


× No keyword cloud information.
  10 in total

1.  Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis.

Authors:  B EISEMAN; W SILEN; G S BASCOM; A J KAUVAR
Journal:  Surgery       Date:  1958-11       Impact factor: 3.982

2.  Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain.

Authors:  François Lamontagne; Annie-Claude Labbé; Olivier Haeck; Olivier Lesur; Mathieu Lalancette; Carlos Patino; Martine Leblanc; Michel Laverdière; Jacques Pépin
Journal:  Ann Surg       Date:  2007-02       Impact factor: 12.969

Review 3.  Clostridium difficile--more difficult than ever.

Authors:  Ciarán P Kelly; J Thomas LaMont
Journal:  N Engl J Med       Date:  2008-10-30       Impact factor: 91.245

4.  Endoscopic fecal microbiota transplantation: "first-line" treatment for severe clostridium difficile infection?

Authors:  Lawrence J Brandt; Thomas Julius Borody; Jordana Campbell
Journal:  J Clin Gastroenterol       Date:  2011-09       Impact factor: 3.062

5.  Predictors of fatal outcome after colectomy for fulminant Clostridium difficile Colitis: a 10-year experience. dr.markelov@gmail.com.

Authors:  Alexey Markelov; David Livert; Harjeet Kohli
Journal:  Am Surg       Date:  2011-08       Impact factor: 0.688

6.  Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications.

Authors:  Ramsey M Dallal; Brian G Harbrecht; Arthur J Boujoukas; Carl A Sirio; Linda M Farkas; Kenneth K Lee; Richard L Simmons
Journal:  Ann Surg       Date:  2002-03       Impact factor: 12.969

Review 7.  Fecal microbiota transplantation and emerging applications.

Authors:  Thomas J Borody; Alexander Khoruts
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-12-20       Impact factor: 46.802

8.  Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection.

Authors:  Matthew J Hamilton; Alexa R Weingarden; Michael J Sadowsky; Alexander Khoruts
Journal:  Am J Gastroenterol       Date:  2012-01-31       Impact factor: 10.864

9.  Duodenal infusion of donor feces for recurrent Clostridium difficile.

Authors:  Els van Nood; Anne Vrieze; Max Nieuwdorp; Susana Fuentes; Erwin G Zoetendal; Willem M de Vos; Caroline E Visser; Ed J Kuijper; Joep F W M Bartelsman; Jan G P Tijssen; Peter Speelman; Marcel G W Dijkgraaf; Josbert J Keller
Journal:  N Engl J Med       Date:  2013-01-16       Impact factor: 91.245

Review 10.  Prediction tools for unfavourable outcomes in Clostridium difficile infection: a systematic review.

Authors:  Claire Nour Abou Chakra; Jacques Pepin; Louis Valiquette
Journal:  PLoS One       Date:  2012-01-24       Impact factor: 3.240

  10 in total
  31 in total

Review 1.  The role of the gut microbiome in systemic inflammatory disease.

Authors:  Jose C Clemente; Julia Manasson; Jose U Scher
Journal:  BMJ       Date:  2018-01-08

2.  Fecal microbiota transplant in severe and severe-complicated Clostridium difficile: A promising treatment approach.

Authors:  Monika Fischer; Brian Sipe; Yao-Wen Cheng; Emmalee Phelps; Nicholas Rogers; Sashidhar Sagi; Matthew Bohm; Huiping Xu; Zain Kassam
Journal:  Gut Microbes       Date:  2016-12-21

Review 3.  Microbiome manipulation with faecal microbiome transplantation as a therapeutic strategy in Clostridium difficile infection.

Authors:  B H Mullish; J R Marchesi; M R Thursz; H R T Williams
Journal:  QJM       Date:  2014-09-04

Review 4.  Understanding the mechanisms of faecal microbiota transplantation.

Authors:  Alexander Khoruts; Michael J Sadowsky
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-06-22       Impact factor: 46.802

5.  Identification of Highly Specific Diversity-Oriented Synthesis-Derived Inhibitors of Clostridium difficile.

Authors:  Jeremy R Duvall; Leanne Bedard; Adel M Naylor-Olsen; Abigail L Manson; Joshua A Bittker; Wenye Sun; Mark E Fitzgerald; Zhenmin He; Maurice D Lee; Jean-Charles Marie; Giovanni Muncipinto; Diane Rush; Deming Xu; Huisheng Xu; Mingliang Zhang; Ashlee M Earl; Michelle A Palmer; Michael A Foley; Joseph P Vacca; Christina A Scherer
Journal:  ACS Infect Dis       Date:  2017-03-07       Impact factor: 5.084

Review 6.  Fecal Microbiota Transplantation: Redefining Surgical Management of Refractory Clostridium difficile Infection.

Authors:  Yao-Wen Cheng; Monika Fischer
Journal:  Clin Colon Rectal Surg       Date:  2020-02-25

Review 7.  Treatment of Severe and Fulminnant Clostridioides difficile Infection.

Authors:  Yao-Wen Cheng; Monika Fischer
Journal:  Curr Treat Options Gastroenterol       Date:  2019-12

8.  Fecal microbiota transplantation for refractory Clostridium difficile colitis in solid organ transplant recipients.

Authors:  R J Friedman-Moraco; A K Mehta; G M Lyon; C S Kraft
Journal:  Am J Transplant       Date:  2014-01-16       Impact factor: 8.086

9.  Predictors of Early Failure After Fecal Microbiota Transplantation for the Therapy of Clostridium Difficile Infection: A Multicenter Study.

Authors:  Monika Fischer; Dina Kao; Shama R Mehta; Tracey Martin; Joseph Dimitry; Ammar H Keshteli; Gwendolyn K Cook; Emmalee Phelps; Brian W Sipe; Huiping Xu; Colleen R Kelly
Journal:  Am J Gastroenterol       Date:  2016-05-17       Impact factor: 10.864

10.  Intestinal microbiota transplantation, a simple and effective treatment for severe and refractory Clostridium difficile infection.

Authors:  Hadeel Zainah; Mona Hassan; Laila Shiekh-Sroujieh; Syed Hassan; George Alangaden; Mayur Ramesh
Journal:  Dig Dis Sci       Date:  2014-07-23       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.